Bioharvest Sciences Ratios (2023-2025) | BHST

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 40.22%44.52%50.73%56.19%51.47%56.80%56.65%58.46%59.73%61.43%
EBT Margin 103.64%53.32%160.07%-123.15%-11.40%-41.12%-40.51%-29.26%-47.46%-27.02%
EBIT Margin 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%
EBITDA Margin 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%
Operating Margin 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%
Net Margin 103.64%53.32%160.07%-123.15%-11.40%-41.12%-40.51%-29.75%-47.92%-27.72%
FCF Margin -17.13%-59.80%-25.37%12.44%-19.07%-27.43%-9.45%-10.15%-18.37%
Efficiency
Inventory Average 3.06M3.11M2.88M3.42M3.83M4.07M4.28M
Assets Average 26.42M25.41M25.80M27.19M31.49M
Equity Average -6.76M2.73M0.23M
Invested Capital 5.68M1.33M1.16M5.33M5.24M-0.88M
Asset Utilization Ratio 0.850.991.071.111.04
Leverage & Solvency
Interest Coverage Ratio 18.0812.95-8.02-0.28-4.70-3.58-1.34-2.96-0.82-0.60
Debt to Equity -1.380.292.94
Debt Ratio 1.370.040.050.16
Equity Ratio -0.990.050.160.05-0.03
Times Interest Earned 18.0812.95-8.02-0.28-4.70-3.58-1.34-2.96-0.82-0.60
Valuation
Enterprise Value -1.74M-1.74M-5.36M-2.39M-5.36M-2.77M-2.39M-3.40M-3.73M-2.39M
Return Ratios
Return on Sales 1.04%0.53%1.60%-1.23%-0.11%-0.41%-0.41%-0.30%-0.48%-0.28%
Return on Capital Employed -1.38%-0.63%-1.06%-0.73%-0.34%
Return on Assets -0.10%-0.51%-0.34%-0.44%-0.38%
Return on Equity -0.77%-4.72%-38.16%